ShockWave Medical, Inc. (SWAV) is currently priced at $334.75, experiencing a slight decline of -0.024%. The trading volume of $3.95 million is notably higher, up by 316.66% compared to the average. Market watchers are closely monitoring SWAV for any significant trading patterns or news impacting its performance.
The latest earnings report for SWAV is awaited for deeper insights. Investors are eager to analyze the company's quarterly earnings, revenue, and profit margin figures to gauge its financial health. Stay tuned for the upcoming earnings date to track the trajectory of ShockWave Medical, Inc.
This real-time financial report provides a snapshot of SWAV's current performance and sets the stage for further analysis as more data becomes available.
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.